With high incidences of diagnostics coupled with the application of aptamers in a variety of diagnosis are estimated to be a major driving factor for the growth of the global aptamers market. Technology advancement is growing the application of aptamers such as Aptagen is the aptamer-beacon (i.e., Apta-beacon) technology to quickly detect biomarkers. According to Goldstein Research, global aptamers market size is expected to reach USD 5.1 billion by 2024, growing at a compounded annual growth rate of 67.2% during the forecast period 2016-2024.
Global aptamers market segmentation has been carried out on the basis of type, technology, application, end user and geography. Based on the end user, academic & research centres accounted for the highest market share, whereas, pharmaceutical & biotechnology companies are expected to be the fastest growing segments in the application of aptamers. Moreover, biosensors market is growing at a considerable CAGR, being one of the major revenue contributors of the total aptamers market.
Further, Global aptamers industry is estimated to be dominated by North America with a market share of 40.0% in 2016 followed by Europe aptamers market share growing at a CAGR of 68.0% during the forecast period. Furthermore, Asia Pacific is the opportunistic market across the globe, owing to the fast growth of the pharmaceutical industry in the region such as India pharmaceutical industry.
Market Segmentation
On the basis of our in-depth analysis, Global Aptamers Market can be segmented as follows:
By Type
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
By Type
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
By Application
- Diagnostic reagents
- Biosensors
- Forensics
- Biodefense
- Cancer
- Therapeutics and drug delivery
By End User
- Bio-Pharmaceutical companies
- Pharmaceutical Companies
- Academic and Research Centres
- Contract Research Organization
By Region
- North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
- Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-aptamers-market-size
“Global Aptamers Market Outlook 2024” contains a detailed overview of the global aptamers market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type, technology, application and end user.
Further, for the in-depth analysis, Global Aptamers Market Report encompasses the market growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market research report also includes competitive outlook of some of the major players profiling of companies such as Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc., Aptagen, Inc, AM Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NeoVentures Biotechnology, Inc., TriLink BioTechnologies, Inc., Vivonics, Inc., etc.
The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents the global aptamers market trends along with a market forecast that will help market consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.
Media Contact
Company Name: Goldstein Research
Contact Person: Steve Blade
Email:Send Email
Phone: +1-6465687747
Address:99 Wall Street, Suite No:- 527
City: New York
State: NY
Country: United States
Website: http://www.goldsteinresearch.com/
